Lifting the fog in intermediate-risk (submassive) PE: full dose, low dose, or no thrombolysis?

Acute pulmonary embolism (PE) is a disease frequently encountered in clinical practice. While the management of haemodynamically stable, low risk patients with acute PE is well established, managing intermediate disease often presents a therapeutic dilemma. In this review, we discuss the various the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhamani, Amyn, Pepke-Zaba, Joanna, Sheares, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436190/
https://www.ncbi.nlm.nih.gov/pubmed/30984375
http://dx.doi.org/10.12688/f1000research.17861.1
_version_ 1783406764907036672
author Bhamani, Amyn
Pepke-Zaba, Joanna
Sheares, Karen
author_facet Bhamani, Amyn
Pepke-Zaba, Joanna
Sheares, Karen
author_sort Bhamani, Amyn
collection PubMed
description Acute pulmonary embolism (PE) is a disease frequently encountered in clinical practice. While the management of haemodynamically stable, low risk patients with acute PE is well established, managing intermediate disease often presents a therapeutic dilemma. In this review, we discuss the various therapeutic options available in this patient group. This includes thrombolysis, surgical embolectomy and catheter directed techniques. We have also explored the role of specialist PE response teams in the management of such patients. ​
format Online
Article
Text
id pubmed-6436190
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher F1000 Research Limited
record_format MEDLINE/PubMed
spelling pubmed-64361902019-04-12 Lifting the fog in intermediate-risk (submassive) PE: full dose, low dose, or no thrombolysis? Bhamani, Amyn Pepke-Zaba, Joanna Sheares, Karen F1000Res Review Acute pulmonary embolism (PE) is a disease frequently encountered in clinical practice. While the management of haemodynamically stable, low risk patients with acute PE is well established, managing intermediate disease often presents a therapeutic dilemma. In this review, we discuss the various therapeutic options available in this patient group. This includes thrombolysis, surgical embolectomy and catheter directed techniques. We have also explored the role of specialist PE response teams in the management of such patients. ​ F1000 Research Limited 2019-03-25 /pmc/articles/PMC6436190/ /pubmed/30984375 http://dx.doi.org/10.12688/f1000research.17861.1 Text en Copyright: © 2019 Bhamani A et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Bhamani, Amyn
Pepke-Zaba, Joanna
Sheares, Karen
Lifting the fog in intermediate-risk (submassive) PE: full dose, low dose, or no thrombolysis?
title Lifting the fog in intermediate-risk (submassive) PE: full dose, low dose, or no thrombolysis?
title_full Lifting the fog in intermediate-risk (submassive) PE: full dose, low dose, or no thrombolysis?
title_fullStr Lifting the fog in intermediate-risk (submassive) PE: full dose, low dose, or no thrombolysis?
title_full_unstemmed Lifting the fog in intermediate-risk (submassive) PE: full dose, low dose, or no thrombolysis?
title_short Lifting the fog in intermediate-risk (submassive) PE: full dose, low dose, or no thrombolysis?
title_sort lifting the fog in intermediate-risk (submassive) pe: full dose, low dose, or no thrombolysis?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436190/
https://www.ncbi.nlm.nih.gov/pubmed/30984375
http://dx.doi.org/10.12688/f1000research.17861.1
work_keys_str_mv AT bhamaniamyn liftingthefoginintermediaterisksubmassivepefulldoselowdoseornothrombolysis
AT pepkezabajoanna liftingthefoginintermediaterisksubmassivepefulldoselowdoseornothrombolysis
AT sheareskaren liftingthefoginintermediaterisksubmassivepefulldoselowdoseornothrombolysis

Ejemplares similares